- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Roy shares promise of bioartificial kidney
By UCSF School of Pharmacy Editorial Staff / Thu Nov 18, 2010
Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years. The bioartificial kidney both filters toxins from the blood and performs many of the metabolic functions of the healthy kidney. And, the bioartificial kidney requires no batteries or external pumps. Roy is a faculty member in the UCSF Department of Bioengineering and Therapeutic Sciences. He discusses The Kidney Project, and the project’s latest research results, on November 16, 2010 in a San Francisco Chronicle newspaper interview with Erin Allday, and on November 17, 2010 on KQED radio’s Forum with Michael Krasney.
More
- UCSF team working on artificial kidney, San Francisco Chronicle, November 16, 2010
- Building artificial kidneys, KQED Forum with Michael Krasney, November 17, 2010
- Roy unveils model of artificial kidney
Tags
Topics:
Category:
Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, PSPG
Related profiles
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
